Bank of New York Mellon’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
+132,473
| New | +$258K | ﹤0.01% | 3853 |
|
|
2023
Q2 | – | Sell |
-6,501
| Closed | -$25.7K | – | 4415 |
|
|
2023
Q1 | $25.7K | Hold |
6,501
| – | – | ﹤0.01% | 4278 |
|
|
2022
Q4 | $19.5K | Sell |
6,501
-51
| -0.8% | -$153 | ﹤0.01% | 4359 |
|
|
2022
Q3 | $36K | Hold |
6,552
| – | – | ﹤0.01% | 4370 |
|
|
2022
Q2 | $29K | Sell |
6,552
-45
| -0.7% | -$199 | ﹤0.01% | 4445 |
|
|
2022
Q1 | $59K | Hold |
6,597
| – | – | ﹤0.01% | 4496 |
|
|
2021
Q4 | $58K | Hold |
6,597
| – | – | ﹤0.01% | 4475 |
|
|
2021
Q3 | $75K | Buy |
+6,597
| New | +$75K | ﹤0.01% | 4375 |
|